Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Equity Ratio (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Equity Ratio data on record, last reported at 27.45 in Q4 2025.

  • For Q4 2025, Equity Ratio fell 197.53% year-over-year to 27.45; the TTM value through Dec 2025 reached 27.45, down 197.53%, while the annual FY2025 figure was 27.45, 197.53% down from the prior year.
  • Equity Ratio reached 27.45 in Q4 2025 per ACBM's latest filing, up from 100.07 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.91 in Q2 2021 and bottomed at 100.07 in Q3 2025.
  • Average Equity Ratio over 5 years is 9.14, with a median of 1.89 recorded in 2023.
  • Peak YoY movement for Equity Ratio: tumbled 1746.94% in 2023, then soared 41.38% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.85 in 2021, then decreased by 16.35% to 0.71 in 2022, then plummeted by 721.44% to 4.4 in 2023, then plummeted by 109.84% to 9.23 in 2024, then plummeted by 197.53% to 27.45 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 27.45 in Q4 2025, 100.07 in Q3 2025, and 5.96 in Q2 2025.